Bleeding Risk Reduction in Relation to Predicted Factor IX Levels in Hemophilia B Patients Receiving Idelvion (rIX-FP)

被引：0
|
作者：
Roberts, John [1 ]
Fosser, Cecilia [2 ]
Tortorici, Michael [1 ]
Veldman, Alex [3 ]
Jacobs, Iris C. [4 ]
Sidhu, Jagdev [5 ]
机构：
[1] CSL Behring, King Of Prussia, PA USA
[2] Cytel, Cambridge, MA USA
[3] CSL Behring, Marburg, Germany
[4] CSL Behring, CRD, King Of Prussia, PA USA
[5] CSL, Parkville, Vic, Australia
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1411.1411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1411
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Efficacy and safety of recombinant fusion protein linking coagulation factor IX with albumin (RIX-FP) in previously treated patients with hemophilia B undergoing a surgical procedure
    Negrier, C.
    Lepatan, L. M.
    Lubetsky, A.
    Karim, F. A.
    Pan-Petesch, B.
    Tagliaferri, A.
    Altisent, C.
    Curtin, J.
    Male, C.
    Lienhart, A.
    Wolko, D.
    Voigt, C.
    Jacobs, I
    Santagostino, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 843 - 843
  • [22] rIX-FP, a recombinant fusion protein linking coagulation factor IX with albumin, demonstrates superior kinetics in cynomolgus monkeys and hemophilia B dogs
    Nolte, M.
    Nichols, T.
    Mueller-Cohrs, J.
    Merricks, E. Parker
    Pragst, I.
    Zollner, S.
    Dickneite, G.
    HAEMOPHILIA, 2012, 18 : 35 - 35
  • [23] Results of a phase I international clinical trial of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in patients with hemophilia B (PROLONG-9FP)
    Santagostino, E.
    Negrier, C.
    Klamroth, R.
    Tiede, A.
    Pabinger, I.
    Trossaert, M.
    Martinowitz, U.
    Altisent, C.
    Tagliaferri, A.
    Rothschild, C.
    Roman, M. A.
    Lopez-Fernandez, M. F.
    Castaman, G.
    Lambert, T.
    Von Depka-Prondzinski, M.
    Voigt, C.
    Jacobs, I.
    Morfini, M.
    HAEMOPHILIA, 2012, 18 : 22 - 22
  • [24] Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program
    Lubetsky, Aaron
    Martinowitz, Uri
    Lissitchkov, Toshko
    Voigt, Christine
    Wolko, Denise
    Jacobs, Iris C.
    Santagostino, Elena
    BLOOD, 2015, 126 (23)
  • [25] Population Pharmacokinetics (PK) of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (RIX-FP) in Adult and Pediatric Patients with Severe Hemophilia B
    Zhang, Y.
    Roberts, J.
    Sidhu, J.
    Bensen-Kennedy, D.
    Feussner, A.
    Voigt, C.
    Jacobs, I.
    Santagostino, E.
    Massimo, M.
    HAEMOPHILIA, 2016, 22 : 102 - 103
  • [26] Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial
    Santagostino, Elena
    Martinowitz, Uri
    Lissitchkov, Toshko
    Pan-Petesch, Brigitte
    Hanabusa, Hideji
    Oldenburg, Johannes
    Boggio, Lisa
    Negrier, Claude
    Pabinger, Ingrid
    Prondzinski, Mario von Depka
    Altisent, Carmen
    Castaman, Giancarlo
    Yamamoto, Koji
    Alvarez-Roman, Maria-Teresa
    Voigt, Christine
    Blackman, Nicole
    Jacobs, Iris
    BLOOD, 2016, 127 (14) : 1761 - 1769
  • [27] Simplifying surgery in haemophilia B: Low factor IX consumption and infrequent infusions in surgical procedures with rIX-FP
    Curtin, Julie
    Santagostino, Elena
    Karim, Faraizah Abdul
    Li, Yanyan
    Seifert, Wilfried
    Negrier, Claude
    THROMBOSIS RESEARCH, 2020, 188 : 85 - 89
  • [28] Efficacy and Safety Results of Prolong-9FP Clinical Program of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B
    Santagostino, Elena
    Voigt, Christine
    Wolko, Denise
    Cole, Grace
    Li, Yanyan
    Jacobs, Iris C.
    BLOOD, 2015, 126 (23)
  • [29] Interim results of a phase IIIb safety and efficacy extension study of a recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in patients with hemophilia B
    Santagostino, Elena
    Voigt, Christine
    Wolko, Denise
    Li, Yanyan
    Strelecki, Mara
    Cole, Grace
    Blackman, Nicole
    Jacobs, Iris
    HAEMOPHILIA, 2016, 22 : 52 - 52
  • [30] Efficacy and Safety of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin ( rIX-FP) in Previously Treated Patients with Hemophilia B Undergoing Major Orthopedic Surgeries
    Negrier, Claude
    Lepatan, Lynda Mae
    Karim, Faralzah
    Lienhart, Anne
    Wolko, Denise
    Voigt, Christine
    Jacobs, Iris C.
    Santagostino, Elena
    BLOOD, 2015, 126 (23)
12345